Vestal Point Capital, LP

CIK 0001974915 · Q2 2026

13F Equity AUM

$4.3B

+19.6% QoQ

Positions

-22 QoQ

AUM Rank

#945

Top 11%

Skill Alpha (FF)

-7.5%/yr^ns

No Clear Edge

Rank #7,913 · Top 95%

vs S&P +18.6%/yr (unadj.)

Quarters Tracked

~2 years

Portfolio Concentration

Top 5: 33.0%Top 10: 50.3%Top 20: 72.7%

BMRN8.1%

NBIX7.4%

ABVX7.3%

UTH5.5%

ELVN4.7%

NRIX4.6%

BCAX3.6%

TSHA3.1%

ARWR3.0%

ABT3.0%

Others (58)49.7%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare96.4%

Unclassified3.6%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 68Median: 0.74%Avg: 1.47%

0–0.5%

26(5.8%)

0.5–1%

13(9.2%)

1–3%

21(40.7%)

3–5%

4(16.0%)

5%+

4(28.3%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 68vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New11Increased31Decreased21Exited33

New Positions

ABT3.0%

+1.4M

Ascendis Pharma A/S2.3%

+375K

IM8N0.6%

+250K

First Tracks Biother…0.5%

+1.0M

AVTX0.3%

+775K

EVMN0.3%

+1.0M

Kailera Therapeutics…0.3%

+575K

IBIO0.1%

+2.6M

SGMT0.1%

+535K

enGene Therapeutics …0.1%

+1.7M

Increased

MYGN0.8%

+4.1M(+248%)

BMRN8.1%

+2.5M(+69%)

NRIX4.6%

+1.6M(+24%)

TSHA3.1%

+1.4M(+8%)

BCRX1.9%

+1.3M(+18%)

ZBH2.8%

+1.2M(+637%)

GLUE2.6%

+997K(+28%)

TRVI1.4%

+933K(+43%)

IRON2.6%

+850K(+121%)

TARS1.5%

+850K(+425%)

Decreased

SLDB0.5%

-2,840,000(-57%)

RVMD2.0%

-1,925,000(-81%)

ANRO0.5%

-1,279,075(-62%)

IMCR1.3%

-966,868(-35%)

RAPP0.7%

-706,229(-49%)

ARWR3.0%

-700,000(-31%)

DYN1.8%

-625,000(-16%)

BBNX0.6%

-611,518(-28%)

RGEN1.3%

-525,000(-57%)

VYGR0.2%

-377,936(-13%)

Exited

-1,100,000

-375,000

-1,324,422

-1,368,159

-1,000,000

-800,000

-481,715

-1,230,888

-1,224,165

-1,850,000

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...